Company profile APVO
There is not enough data for Aptevo Therapeutics -immunotherapy to provide analysis
There is not enough data for Aptevo Therapeutics -immunotherapy to provide correlation calculation
There is not enough data for Aptevo Therapeutics -immunotherapy to provide analysis
After 34 days of this quarter the interest is at 422.0. Based on that we can calculate that during remaining 58 days it will total up to 1142.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 544 |
| 2019 | 956 75.7% QoQ | 951 -0.5% QoQ | 914 -3.9% QoQ | 975 79.2% YoY 6.7% QoQ |
| 2020 | 990 3.6% YoY 1.5% QoQ | 814 -14.4% YoY -17.8% QoQ | 936 2.4% YoY 15.0% QoQ | 929 -4.7% YoY -0.7% QoQ |
| 2021 | 869 -12.2% YoY -6.5% QoQ | 915 12.4% YoY 5.3% QoQ | 951 1.6% YoY 3.9% QoQ | 917 -1.3% YoY -3.6% QoQ |
| 2022 | 886 2.0% YoY -3.4% QoQ | 897 -2.0% YoY 1.2% QoQ | 859 -9.7% YoY -4.2% QoQ | 860 -6.2% YoY 0.1% QoQ |
| 2023 | 947 6.9% YoY 10.1% QoQ | 946 5.5% YoY -0.1% QoQ | 900 4.8% YoY -4.9% QoQ | 422 -50.9% YoY -53.1% QoQ |
The average 5 years interest of cancer treatment was 70.41 per week. The last year interest of cancer treatment compared to the last 5 years has changed by 0.24%. The interest for cancer treatment is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by -1.58%.
After 38 days of this quarter the interest is at 33.0. Based on that we can calculate that during remaining 53 days it will total up to 79.0. APVO436 expected interest is significantly lower compared to same quarter last year (-45.1%) but higher than previous quarter (+51.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 210 inf% QoQ | 95 -54.8% QoQ | 69 -27.4% QoQ |
| 2020 | 59 inf% YoY -14.5% QoQ | 114 -45.7% YoY 93.2% QoQ | 89 -6.3% YoY -21.9% QoQ | 83 20.3% YoY -6.7% QoQ |
| 2021 | 205 247.5% YoY 147.0% QoQ | 164 43.9% YoY -20.0% QoQ | 133 49.4% YoY -18.9% QoQ | 126 51.8% YoY -5.3% QoQ |
| 2022 | 51 -75.1% YoY -59.5% QoQ | 146 -11.0% YoY 186.3% QoQ | 93 -30.1% YoY -36.3% QoQ | 77 -38.9% YoY -17.2% QoQ |
| 2023 | 144 182.4% YoY 87.0% QoQ | 130 -11.0% YoY -9.7% QoQ | 0 -100.0% YoY -100.0% QoQ | 52 -32.5% YoY inf% QoQ |
| 2024 | 33 -77.1% YoY -36.5% QoQ | - | - | - |
The average 5 years interest of APVO436 was 7.97 per week. The last year interest of APVO436 compared to the last 5 years has changed by -13.43%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -9.21%.
There is not enough data for APV-527 to provide analysis
There is not enough data for APV-527 to provide correlation calculation
There is not enough data for APV-527 to provide analysis
There is not enough data for immunotherapeutic candidates to provide analysis
There is not enough data for immunotherapeutic candidates to provide correlation calculation
There is not enough data for immunotherapeutic candidates to provide analysis
There is not enough data for clinical-stage biotechnology company to provide analysis
There is not enough data for clinical-stage biotechnology company to provide correlation calculation
There is not enough data for clinical-stage biotechnology company to provide analysis
There is not enough data for bi-specific antibody to provide analysis
There is not enough data for bi-specific antibody to provide correlation calculation
There is not enough data for bi-specific antibody to provide analysis
There is not enough data for bispecific ADAPTIR candidate to provide analysis
There is not enough data for bispecific ADAPTIR candidate to provide correlation calculation
There is not enough data for bispecific ADAPTIR candidate to provide analysis
After 38 days of this quarter the interest is at 42.0. Based on that we can calculate that during remaining 53 days it will total up to 101.0. 4-1BB expected interest is significantly lower compared to same quarter last year (-53.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 88 | 105 19.3% QoQ | 132 25.7% QoQ | 192 45.5% QoQ |
| 2020 | 133 51.1% YoY -30.7% QoQ | 241 129.5% YoY 81.2% QoQ | 114 -13.6% YoY -52.7% QoQ | 105 -45.3% YoY -7.9% QoQ |
| 2021 | 238 78.9% YoY 126.7% QoQ | 157 -34.9% YoY -34.0% QoQ | 85 -25.4% YoY -45.9% QoQ | 161 53.3% YoY 89.4% QoQ |
| 2022 | 205 -13.9% YoY 27.3% QoQ | 282 79.6% YoY 37.6% QoQ | 243 185.9% YoY -13.8% QoQ | 329 104.3% YoY 35.4% QoQ |
| 2023 | 217 5.9% YoY -34.0% QoQ | 238 -15.6% YoY 9.7% QoQ | 177 -27.2% YoY -25.6% QoQ | 86 -73.9% YoY -51.4% QoQ |
| 2024 | 42 -80.6% YoY -51.2% QoQ | - | - | - |
The average 5 years interest of 4-1BB was 13.73 per week. The last year interest of 4-1BB compared to the last 5 years has changed by -1.53%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 24.38%.
After 38 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 53 days it will total up to 62.0. 5T4 expected interest is significantly lower compared to previous quarter (-50.8%) and same quarter last year (-51.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 142 | 137 -3.5% QoQ | 173 26.3% QoQ | 115 -33.5% QoQ |
| 2020 | 80 -43.7% YoY -30.4% QoQ | 121 -11.7% YoY 51.2% QoQ | 142 -17.9% YoY 17.4% QoQ | 139 20.9% YoY -2.1% QoQ |
| 2021 | 89 11.2% YoY -36.0% QoQ | 189 56.2% YoY 112.4% QoQ | 119 -16.2% YoY -37.0% QoQ | 70 -49.6% YoY -41.2% QoQ |
| 2022 | 132 48.3% YoY 88.6% QoQ | 82 -56.6% YoY -37.9% QoQ | 32 -73.1% YoY -61.0% QoQ | 167 138.6% YoY 421.9% QoQ |
| 2023 | 127 -3.8% YoY -24.0% QoQ | 79 -3.7% YoY -37.8% QoQ | 84 162.5% YoY 6.3% QoQ | 126 -24.6% YoY 50.0% QoQ |
| 2024 | 26 -79.5% YoY -79.4% QoQ | - | - | - |
The average 5 years interest of 5T4 was 9.12 per week. The last year interest of 5T4 compared to the last 5 years has changed by -15.24%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -36.22%.
There is not enough data for APVO603 to provide analysis
There is not enough data for APVO603 to provide correlation calculation
There is not enough data for APVO603 to provide analysis
There is not enough data for APVO711 to provide analysis
There is not enough data for APVO711 to provide correlation calculation
There is not enough data for APVO711 to provide analysis
There is not enough data for APVO442 to provide analysis
There is not enough data for APVO442 to provide correlation calculation
There is not enough data for APVO442 to provide analysis
There is not enough data for ADAPTIR-FLEX to provide analysis
There is not enough data for ADAPTIR-FLEX to provide correlation calculation
There is not enough data for ADAPTIR-FLEX to provide analysis
There is not enough data for Alligator Bioscience AB collaboration to provide analysis
There is not enough data for Alligator Bioscience AB collaboration to provide correlation calculation
There is not enough data for Alligator Bioscience AB collaboration to provide analysis